(B) Representative southern blot analysis confirming homologous recombination in the positive ES clone used for the production of chimeric mice.
(C) PCR-based genotyping using primers of wild type (+/+) and null (-/-) alleles of the targeted locus. The locations of the primers are indicated with blue arrows in S1A.
(D) Set9 expression levels are not affected by TGF-β treatment. Primary lung fibroblasts from wild type (WT) and Set9-KO mice were left untreated or treated with 5 ng/ml TGF-β for the indicated time periods. Whole cell extracts were analyzed in western blots using antibodies against Set9 (upper panel) and TFIIB (lower panel).
(E) Wild type (WT) and Set9-depleted (shSet9) Hela cells were left untreated or treated with 5 ng/ml TGF-β and/or with 1 µM (R)-PFI-2 inhibitor, as indicated. Whole cell extracts were analyzed in western blots using antibodies against Set9 (upper panel) and TFIIB (lower panel).
(F) qPCR analysis of the mRNA levels of the indicated panel of genes involved in EpithelialMesenchymal Transition (HmgA2, Has2, Twist, Snai1) in isolated primary lung fibroblasts that were treated in vitro with 5 ng/ml TGF-β for the indicated time periods (h= hours). Lung fibroblasts were from wild type (WT) mice (black bars) or Set9-KO mice (grey bars). Wild type mice treated with 1 µM (R)-PFI-2 Set9 inhibitor (white bars). Bars represent mean values of mRNA levels normalized to Gapdh mRNA ± sem, from 4 experiments performed in triplicates. * p value < 0.05. (two-tailed Student's t-test).
(G) Primary lung fibroblasts were left untreated (-) or treated with 5 ng/ml TGF-β (+) for 6 hours. Whole cell extracts were subjected to western blot analysis using antibodies against p53 or GAPDH.
(H) Wild type and sh-Set9-expressing H1299 human lung carcinoma cells were treated with 5 ng/ml TGF-β for the indicated time points. The mRNA levels of COL7A1, SERPINE1 and CTGF were evaluated by qPCR. Bars represent mean values of mRNA levels normalized to GAPDH mRNA ± sem from 4 experiments performed in triplicates. * p value < 0.05. (two-tailed Student's ttest). 584.20 y' 5 8 . 0 1 2 9 .1 2 7 1 .2 3 2 8 .2 4 6 5 . 3 6 0 2 . 3 7 3 9 . 4 8 3 6 . 4 9 7 3 . 5 1 0 7 0 . 5 1 1 6 7 . 6 1 2 6 8 . 6 1 3 5 5 . 7 1 4 1 2 . 7 1 4 8 3 .7 1 5 4 0 .8 1 3 5 5 .7 1 6 8 2 .8 1 7 3 9 .8 1 7 9 6 .9 1 8 6 7 .9 1 9 9 6 . 9 2 0 6 8 . 0 2 1 8 3 . 0 2 2 9 6 . 1 1 4 7 .1 2 6 0 . 2 3 7 5 . 2 4 4 6 .3 5 7 5 .3 6 4 6 .3 7 0 3 .4 7 6 0 .4 9 0 2 .5 9 5 9 .5 1 0 3 0 . 5 1 0 8 7 . 5 1 1 7 4 . 6 1 2 7 5 . 6 1 3 7 2 . 7 1 4 6 9 . 7 1 6 0 6 .8 1 7 0 3 .8 1 8 4 0 .9 1 9 7 7 .9 2 1 1 5 . 0 2 1 7 2 .0 2 3 1 4 .1 2 3 8 5 . (C) Wild type (WT) and sh-Set9 expressing (sh-Set9) HeLa cells were transfected with Smad7-specific smart pool siRNAs or control siRNA, as indicated. Three days after transfection endogenous levels of Smad7 and GAPDH proteins were evaluated by western blot analysis.
Figure S3 (Related to Figure 3)
Specificity of αMe-Smad7 antibody. 10 ng of recombinant 6xHis-tagged wild type and K70R mutant forms of Smad7 proteins were methylated in vitro with 100 ng GST-Set9 and 1 µM cold SAM. The reaction products were analyzed in western blots using αMe-Smad7 or αSmad7 antibodies. Note that the αMe-Smad7 did not recognize non-methylated Smad7 proteins (lanes 2-3 in left panel).
Figure S4 (Related to Figure 4)
Set9 depletion reduces TGF-β-RI protein levels. Wild type (WT) and sh-Set9 Hela cells or wild type (WT) and Set9-KO lung fibroblasts were treated with 5 ng/ml TGF-β for 6 hours. The endogenous levels of TGF-β-RI protein were evaluated in western blots using antibodies against TGF-β-RI (upper panel) and GAPDH (lower panel). Masson's trichrome staining Deparaffinized formalin-fixed lung tissues were rehydrated and incubated with Bouin's solution (25 vol 37% formaldehyde, 70 vol saturated picric acid and 5 vol acetic acid) for 1 hr at 56 o C. After extensive washing with H 2 O the sections were stained for 10 min with Wegert's solution (0.5% Hematoxylin, 0.6% Ferric chloride 50% ethanol and 0.5 v/v concentrated HCl). The sections were washed with H 2 O and stained for 5 min with biebrich scarlet-acid fuchsin solution, made by mixing 90 ml 1% biebrich scarlet, 10 ml 1% acid fuchsin and 1 ml acetic acid. After washing with H 2 O the sections were incubated for 5 min with 1% phosphomolybdic / phosphotungstic Acid solution followed by washes and staining with 2.5% aniline-blue in 2% acetic acid for 10 minutes.
Measurements of lung mechanics
Mice were anesthetized with intra-peritoneal injection of 0.051 ml/10g bodyweight of a mixture of ketamine (20 mg/ml, Merial SAS) and xylazine (1.3 mg/ml, Bayer AG). Once surgical anaesthesia had been established the trachea was exposed, cannulated with a blunted metal 18-gauge needle and connected to a computer-controlled small animal ventilator (FlexiVent, SCIREQ) (Apostolou et al., 2012) . The animals were placed on a 37°C heating pad to maintain body temperature during the experiment and ventilated with a tidal volume of 8 ml/kg, at a normal respiratory rate (150 breaths/minute). A positive end-expiratory pressure of 0.2 kPa was established by placing the expiratory line in a water trap. Each animal was paralyzed with intra-peritoneal injection of 0.05 ml/10g bodyweight of rocuronium bromide (0.01 mg/ml, N.V. Organon) to suppress spontaneous breathing and allowed to equilibrate on the ventilator. The lung volume history of the mice was standardized prior to measurement of lung mechanics using three deep inflations at total lung capacity. Interference of the ventilator's mechanical parts or the tracheal cannula to the measurements was eliminated using dynamic calibration as previously described (Tomioka et al., 1985) .
Mass spectrometry
Tryptic digestion of in vitro methylated proteins using 1 M cold S-Adenosyl-Methionine was performed using the filter-aided sample preparation digestion protocol (Wisniewski et al., 2009 ). Proteins were dissolved in a solution of 8M urea, 4% (w/v) SDS and 100mM Tris, pH 8.6 and added on top of a centrifugal filtering unit with a 10 kDa molecular weight cut-off (Sartorius). Protein reduction, alkylation and tryptic digestion were performed step by step in the centrifugal unit. After 16 hr digestion at 37°C, peptides were eluted twice with 150 µL water and evaporated to dryness. Peptides were reconstituted in 2% acetonitrile/0.1% formic acid. 2 μg of dissolved peptides were pre-concentrated on a C18 trap column and then separated on a 50-cm nano-column (75 μm ID, particle size 2 μm, 100Å, Acclaim PepMap RSLC -Thermo Scientific) coupled via a nano-electrospray source to an LTQ Orbitrap XL (Thermo Scientific) mass spectrometer. Peptides were separated with a linear gradient from 2% to 95% acetonitril in 0.1% formic acid in 210 minutes. A mass spectrometric top6 method for data-dependent acquisition at 60K resolving power was used. Full scans (m/z range 300-2000) were acquired in the Orbitrap mass spectrometer after accumulating up to 10 6 charges. The six most abundant and multiple charged precursors were fragmented using collision-induced dissociation and their MS/MS spectra were acquired in the ion trap. Dynamic exclusion was enabled for 90 sec. Raw result files were analyzed using Thermo Scientific™ Proteome Discoverer™ software version 2.0 using SEQUEST HT (1.17). Peak lists were searched against the Uniprot mouse-specific database with an initial mass deviation of 10 ppm, fragmentation mass deviation of 0.8 Da and trypsin digestion specificity allowing up to two missed cleavages. Carbamidomethylation, oxidation of methionine, mono-, di-, tri-methylation of lysine and acetylation of the protein N-terminus were used as variable modifications. The peptides were filtered according to their XCorr score versus charge state and only high confidence peptides were evaluated for their methylation status.
Antibodies
Mouse monoclonal anti-Smad7 (R&D Systems, #MAB2029), rabbit polyclonal anti-Smad7 (Life Technologies, #42-0400), anti-GAPDH (Santa Cruz Biotechnology, sc-32233), anti-Set7/9 (Millipore, #04-805), anti-TFIIB (Santa Cruz Biotechnology, sc-225), anti-Ubiquitin (Santa Cruz Biotechnology, sc-8017), anti-HA-tag (Santa Cruz Biotechnology, sc-7392), anti-acetyl-lysine (Abcam, ab21623), anti-RNF111 (Sigma, HPA038576), anti-Smurf1 (Cell Signaling, #2174), anti-Smurf2 (Cell Signaling, #12024), anti-TGF-RI (Cell Signaling, #3712), anti-SMA (Sigma Aldrich #C6198), anti-CD45 (BD Biosciences, #550539), anti-p53 (Abcam, ab1101). Methylation-specific Smad7 antibody was raised in rabbits against the peptide Ac-C(Ahx)AVRGAKme 1 GHH-amide, containing Ahx six-carbon spacer, by New England Peptide, that was subjected to double affinity purification against methylated and non-methylated peptides. The specificity of the antibody was verified by western blot analysis of in vitro methylated Smad7 proteins ( Figure S3 ).
Primer sequences
The nucleotide sequences of primer sets used were the following: 
